	Dasatinib-induced cervicofacial oedema in chronic myeloid leukaemia blast crisis. BMJ Case Rep Ledesma MMP, Amadore RA Jr, Ong AJK, Quero-Taggaoa AKH. PMID: 42618311 [PubMed - indexed for MEDLINE]
	Neurovascular coupling alterations in children with acute lymphoblastic leukemia after chemotherapy: an ASL and rs-fMRI study. Brain Res Bull Zhou T, Guo Y, Liu Y, Shi Q, Li F, Chen X. PMID: 42617922 [PubMed - as supplied by publisher]
	Interim Positron Emission Tomography-Adapted Treatment Strategies for Classic Hodgkin Lymphoma: Insights From Korean Real-World Data. J Korean Med Sci Byeon S, Kang KW, Kwak K, Yoo KH, Yoon SE, Kim WS, Kim SJ. PMID: 42617191 [PubMed - indexed for MEDLINE]
	A phase 1 feasibility trial of BE-CAR33, an "off-the-shelf" base-edited CAR33 T cell therapy for acute myeloid leukemia. Sci Transl Med Georgiadis C, Chiesa R, Rashed H, Hughes BK, Preece R, Gough O, Pinner D, Adams S, Thomas R, Etuk A, Mishra A, Zhan H, Braybrook T, Gilmour K, Potter V, Bartram J, Ancliff P, Sauer M, Qasim W, Base Edited-CAR T cell group, Base-Edited CAR T Group. PMID: 42616838 [PubMed - indexed for MEDLINE]
	Spontaneous lymphoproliferation differentiates two groups of HTLV-1 asymptomatic carriers: with and without high cell proliferation and death. Immunol Res de Souza Porto M, Mitiko T, Folgosi V, Vasconcelos D, Domingues M, Haziot M, Smid J, Marcusso R, Nukui Y, Oliveira ACP, Assone T, Casseb J, Benard G. PMID: 42616278 [PubMed - indexed for MEDLINE]
	Three decades of anaplastic lymphoma kinase: from physiological roles to cancer and immune evasion. Cancer Metastasis Rev Amin HM, Aminnia S, Saber MM, Kannan MK, Hung J. PMID: 42616237 [PubMed - indexed for MEDLINE]
	Prognostic value of the CONUT score in newly diagnosed diffuse large B-cell lymphoma. Oncol Lett Seçilmi, Afacan Öztürk HB, Ay Karaku, Dikyar A, Acar K, Güne. PMID: 42614724 [PubMed]
	Mouse models of B cell lymphomas on the basis of genetic features. Front Immunol Yuan M, Wang JQ. PMID: 42614320 [PubMed - indexed for MEDLINE]
	Mapping the Global Clinical Trial Landscape of Chimeric Antigen Receptor T-Cell Therapy for Chronic Lymphocytic Leukemia: Current Status and Future Perspectives. Am J Ther Liao Y, Li Y, Feng L. PMID: 42613665 [PubMed - as supplied by publisher]
	Deep learning-based PET/CT mixture-of-experts model for relapse risk stratification in relapsed/refractory classical hodgkin lymphoma: a multicenter study. Eur J Nucl Med Mol Imaging Jiang C, Jiang Z, Zhang X, Zhang Z, Teng Y, Zhou H, Jiang M, Xu J, Ding C, Guo R, Li K, Tian R. PMID: 42613444 [PubMed - as supplied by publisher]
	Nutritional outcomes associated with enteral versus parenteral nutritional support during intensive induction chemotherapy for acute myeloid leukemia. Support Care Cancer Schwarz M, Lebreton A, Lester MA, Marchand T, Houot R, Giltat A, Mokeddem C, Mear JB, Darras E, Orvain C, Hunault M, Tanguy-Schmidt A. PMID: 42613390 [PubMed - indexed for MEDLINE]
	Prognostic Impact of Sequential Measurable Residual Disease and KIT Variant Status in Pediatric Core-Binding Factor Acute Myeloid Leukemia: A Retrospective Multicenter Study of the Taiwan Pediatric Oncology Group. Ann Lab Med Yeh TC, Jaing TH, Liu HC, Chen SH, Wang SC, Hsiao CC, Chiou SS, Hou JY, Lin PC, Huang FL, Yang SH, Huang TY, Yang CP, Shih LY. PMID: 42613183 [PubMed - as supplied by publisher]
	Danburstotug, an anti-PD-L1 antibody, in relapsed/refractory extra-nodal natural killer/T-cell lymphoma: The phase 2 DISTINKT study. Br J Haematol Kim WS, Kim SJ, Jo JC, Yoon SE, Koh Y, Yang DH, Yoon DH, Cho J, Lee SY, Kim S, Kang S, Hwang W, Kim H, Yun HY, Jeon J, Ahn C, Kim HT. PMID: 42613033 [PubMed - as supplied by publisher]
	Standardized Multicolor Flow Cytometry Protocol for Measurable Residual Disease Assessment in Acute Leukemia. J Vis Exp Li L. PMID: 42611945 [PubMed - indexed for MEDLINE]
	Dose optimization of single-agent inotuzumab ozogamicin in adults with relapsed/refractory acute lymphoblastic leukemia. Leuk Lymphoma DeAngelo DJ, Chen Y, Cassaday RD, Hibma JE, Yang DZ, Garrett M, Zhang F, Dimitrov SH, Vandendries ER, Kantarjian HM. PMID: 42611806 [PubMed - as supplied by publisher]
	Erythroblastic sarcoma with biallelic TP53 mutations and novel NUP214:: ABL1-new finding in erythroblastic sarcoma/acute erythroid leukemia. J Hematop Manzo R, Xia C, Tang Z, Khoury JD, Zhang S. PMID: 42611361 [PubMed - indexed for MEDLINE]
	Quantitative Integration of Targeted and Nontargeted Metabolomics Using Multi-Stable Isotope Chemical Tagging with UHPLC-QToF MS: Application to Myeloid Leukemia Metabolism. Anal Chem Takayama T, Tsutsumi T, Higuchi T, Takahashi S, Hayashi Y, Inoue K. PMID: 42610920 [PubMed - indexed for MEDLINE]
	Blinatumomab administration in the outpatient setting: Safety and health care utilization. Cancer Valtis YK, Frost BF, Nemirovsky D, Derkach A, Chin KK, Salman MY, Boussi L, Ovalle NT, Baxter E, Mercurio A, Stein EM, Geyer MB, Schrag D, Kelkar AH, DeAngelo DJ, Luskin MR, Park JH, Chen EC. PMID: 42610826 [PubMed - indexed for MEDLINE]
	Therapeutic Exercise Protocol During Hospitalization in Pediatric Oncohematological Patients: Randomized Clinical Trial. Physiother Res Int Carniel CF, Souza BC, Leite HF, Zangirolami-Raimundo J, Raimundo RD. PMID: 42610644 [PubMed - indexed for MEDLINE]
	Prognostic relevance of RUNX1 mutations at acute myeloid leukemia diagnosis and as measurable residual disease marker before and after allogeneic stem cell transplantation. Haematologica Backhaus D, Bischof L, Jendro J, Ussmann J, Brauer D, Herling M, Vucinic V, Franke GN, Platzbecker U, Cross M, Metzeler KH, Schwind S, Jentzsch M. PMID: 42610424 [PubMed - as supplied by publisher]

Articles 1 - 20 / 169756

Page 1 of 8488



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy